PSNL

9.35

2.19% 0.20

Dopo l'orario di chiusura: 9.84 0.49 +5.24%

Personalis Inc (PSNL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$9.15

Aprire:

$9.06

Volume 24 ore:

1.36M

Relative Volume:

0.92

Capitalizzazione di mercato:

$830.32M

Reddito:

$73.48M

Utile/perdita netta:

$-108.30M

Rapporto P/E:

-4.1556

EPS:

-2.25

Flusso di cassa netto:

$-67.17M

1 W Prestazione:

+17.46%

1M Prestazione:

-2.20%

6M Prestazione:

+39.97%

1 anno Prestazione:

+56.35%

Intervallo 1D:

$9.00

$9.74

Intervallo di 1 settimana:

$7.7201

$9.74

Portata 52W:

$2.8262

$11.40

Personalis Inc Stock (PSNL) Company Profile

Nome

Personalis Inc

Settore

Healthcare (1116)

Industria

Diagnostics & Research (54)

Telefono

650-752-1300

Indirizzo

6600 DUMBARTON CIRCLE, FREMONT, CA

Dipendente

229

Cinguettio

@PersonalisInc

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

PSNL's Discussions on Twitter

Confronta PSNL con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PSNL Personalis Inc	9.35	812.56M	73.48M	-108.30M	-67.17M	-2.25
TMO Thermo Fisher Scientific Inc	617.15	233.21B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	235.57	167.12B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	714.55	56.44B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	147.81	41.84B	6.95B	1.30B	1.15B	4.5696
IQV Iqvia Holdings Inc	244.29	40.96B	15.90B	1.28B	2.21B	7.2842

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Equal-Weight
2025-05-15	Iniziato	Guggenheim	Buy
2025-03-17	Iniziato	Craig Hallum	Buy
2023-02-06	Aggiornamento	Needham	Hold → Buy
2022-01-07	Aggiornamento	BofA Securities	Neutral → Buy
2021-11-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-11-03	Downgrade	Needham	Buy → Hold
2021-10-15	Ripresa	Cowen	Outperform
2021-09-20	Reiterato	Needham	Buy
2021-05-06	Aggiornamento	Oppenheimer	Perform → Outperform
2021-01-28	Iniziato	Truist	Buy
2021-01-04	Downgrade	BofA Securities	Buy → Neutral
2020-11-12	Reiterato	Needham	Buy
2020-11-06	Downgrade	Oppenheimer	Outperform → Perform
2020-10-19	Iniziato	Citigroup	Buy
2020-10-08	Iniziato	BTIG Research	Buy
2020-08-27	Iniziato	H.C. Wainwright	Buy
2020-08-18	Iniziato	Needham	Buy
2019-09-26	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-07-15	Iniziato	BofA/Merrill	Neutral
2019-07-15	Iniziato	Cowen	Outperform
2019-07-15	Iniziato	Morgan Stanley	Overweight
2019-07-15	Iniziato	Oppenheimer	Outperform

Mostra tutto

Personalis Inc Borsa (PSNL) Ultime notizie

06:33 AM

Personalis (NASDAQ:PSNL) delivers shareholders splendid 54% CAGR over 3 years, surging 15% in the last week alone - simplywall.st

06:33 AM

Jan 03, 2026

Personalis (NASDAQ:PSNL) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Jan 03, 2026

Jan 02, 2026

Will Personalis Inc stock remain a Wall Street favoriteJuly 2025 Analyst Calls & Stepwise Entry and Exit Trade Signals - moha.gov.vn

Jan 02, 2026

Quant Funds Rotate Into Pavna Industries Limited StockTechnical Analysis Insights & Stay Invested. Stay Smart. - earlytimes.in

Jan 02, 2026

Dec 30, 2025

Morgan Stanley Analyst Initiates Equal Weight Rating On Personalis, Inc. (PSNL) - Insider Monkey

Dec 30, 2025

Personalis Outpaces The Market With Cancer Test Breakthroughs - Finimize

Dec 30, 2025

Dec 26, 2025

Personalis, Inc. (NASDAQ:PSNL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 26, 2025

Personalis, Inc. (NASDAQ:PSNL) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Dec 26, 2025

Personalis, Inc. (NASDAQ:PSNL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 26, 2025

Dec 21, 2025

Will Personalis Inc. (04X) stock split increase liquidityRate Cut & Entry and Exit Point Strategies - Улправда

Dec 21, 2025

Dec 20, 2025

How Personalis Inc. stock reacts to bond yieldsWeekly Trading Summary & Safe Entry Point Alerts - ulpravda.ru

Dec 20, 2025

Dec 19, 2025

Is Personalis Inc. stock attractive for hedge funds2025 Bull vs Bear & Community Consensus Trade Signals - Улправда

Dec 19, 2025

Personalis (NASDAQ:PSNL) Sees Strong Trading VolumeHere's Why - MarketBeat

Dec 19, 2025

Will Personalis Inc. stock remain a Wall Street favoriteJuly 2025 Trends & Free High Return Stock Watch Alerts - Bölüm Sonu Canavarı

Dec 19, 2025

Nasdaq Moves: How Personalis Inc. stock reacts to bond yieldsWeekly Stock Recap & Reliable Price Action Trade Plans - ulpravda.ru

Dec 19, 2025

Dec 18, 2025

Aug Opening: How risky is Personalis Inc. stock nowTrade Exit Summary & Daily Price Action Insights - Улправда

Dec 18, 2025

Revenue Check: Will Personalis Inc. (04X) stock split increase liquidityJuly 2025 Price Swings & Daily Price Action Insights - Улправда

Dec 18, 2025

How risky is Personalis Inc. stock nowJuly 2025 Earnings & Safe Investment Capital Preservation Plans - Улправда

Dec 18, 2025

Dec 17, 2025

Personalis study shows cancer blood test predicts immunotherapy outcomes By Investing.com - Investing.com Nigeria

Dec 17, 2025

Personalis study shows cancer blood test predicts immunotherapy outcomes - Investing.com

Dec 17, 2025

Personalis announces new publication applying ultrasensitive ctDNA testing - marketscreener.com

Dec 17, 2025

Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors - Business Wire

Dec 17, 2025

Dec 14, 2025

Personalis (NASDAQ:PSNL) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Dec 14, 2025

Dec 13, 2025

Personalis (NASDAQ:PSNL) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Dec 13, 2025

Dec 11, 2025

New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer - Business Wire

Dec 11, 2025

Dec 10, 2025

Why Analysts See Personalis Story Shifting With Medicare Tailwinds And Biopharma Headwinds - Yahoo Finance

Dec 10, 2025